5-hydroxydopamine has been researched along with betaxolol in 1 studies
| Studies (5-hydroxydopamine) | Trials (5-hydroxydopamine) | Recent Studies (post-2010) (5-hydroxydopamine) | Studies (betaxolol) | Trials (betaxolol) | Recent Studies (post-2010) (betaxolol) |
|---|---|---|---|---|---|
| 71 | 0 | 0 | 717 | 227 | 82 |
| Protein | Taxonomy | 5-hydroxydopamine (IC50) | betaxolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.0371 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
1 other study(ies) available for 5-hydroxydopamine and betaxolol
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |